NCT06665919: The Study of CYP2C19 Genotype-Guided Clopidogrel Treatment Models |
|
|
| Active, not recruiting | N/A | 283 | RoW | CYP2C19 Genotype-Guided Clopidogrel Treatment, CYP2C19 Genotype Guided Antiplatelet Treatment Alternative to Clopidogrel, The Conventional Clopidogrel Treatment | Vistamedi Ltd., Tbilisi State Medical University | Coronary Artery Disease, Clopidogrel Resistance, Coronary Thrombosis, Adverse Cardiac Events, Bleeding, Hospitalisations, Death, Death From Cardiovascular Disease | 03/25 | 04/25 | | |